Ansbert Gadicke, Director, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 100,978 shares at $29.09 ($3.0M) on 2021-08-27, disclosed to the SEC on 2021-08-31.
Open-market sale of $3.0M CGEM by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.09 | 1,846 | $54K | 1.8% |
| 2 | $29.09 | 1,846 | $54K | 1.8% |
| 3 | $29.09 | 13,357 | $389K | 13.2% |
| 4 | $29.09 | 13,357 | $389K | 13.2% |
| 5 | $29.30 | 4,285 | $126K | 4.3% |
| 6 | $29.30 | 4,285 |
| $126K |
| 4.3% |
| 7 | $29.30 | 31,001 | $908K | 30.8% |
| 8 | $29.30 | 31,001 | $908K | 30.8% |
| Total | $29.24 avg | 100,978 | $3.0M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |